Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
08.05.26
/
50%
€22.10
Target price
08.05.27
€36.67
Performance (%)
-14.03%
Price
08.06.26
?
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.03%. This prediction currently runs until 08.05.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.371% | -7.371% |
| iShares Core DAX® | -1.862% | |
| iShares Nasdaq 100 | -3.322% | |
| iShares Nikkei 225® | -2.299% | |
| iShares S&P 500 | -1.313% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target lowered by Guggenheim from $52.00 to $43.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.00
05.01.26
05.01.26
€44.47
05.01.27
05.01.27
-6.38%
08.06.26
08.06.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-40.63%
08.06.26
08.06.26